Deshmukh, Vaishali
Chaudhury, Tirthankar
Chadha, Manoj
Chawla, Manoj
Mukherjee, Sagarika
Pitale, Shailesh
Basu, Debasis
Gadekar, Arvind
Menon, Shalini
Trivedi, Chirag
Salvi, Vaibhav
Ramakrishnan, Santosh
Goyal, Ghanshyam
Funding for this research was provided by:
Sanofi
Article History
Received: 28 April 2023
Accepted: 31 August 2023
First Online: 4 October 2023
Declarations
:
: Manoj Chadha has received speaker fees from Eli Lilly and Company, Novo Nordisk and Sanofi. Manoj Chawla is on the advisory board for/has a speaker contract with/has a consultancy agreement with Sanofi India, Novo Nordisk India Pvt. Ltd., Eli Lilly India, Boehringer Ingelheim, MSD, AstraZeneca Pharma India Ltd., Novartis, Eris Lifesciences, and USV. Vaishali Deshmukh, Tirthankar Chaudhury, Sagarika Mukherjee, Shailesh Pitale, Debasis Basu, Santosh Ramakrishnan, Ghanshyam Goyal have nothing to disclose. Arvind Gadekar, Shalini Menon, Chirag Trivedi, and Vaibhav Salvi are employees of Sanofi and may hold stock options. The authors individually and collectively are responsible for all content and editorial decisions and did not receive any payment from Sanofi directly or indirectly (through a third party) related to the development or presentation of this study.
: Being a retrospective analysis, as per the applicable local regulations, approval of the study protocol, protocol amendments, and other relevant documents from an independent ethics committee registered with the National Ethics Committee Registry for Biomedical and Health Research, Department of Health Research (NECRBHR, DHR) were obtained prior to the study initiation. The primary studies were conducted in accordance with the ethical principles laid down by the Helsinki Declaration of 1964, and its later amendments, all international applicable guidelines, and national laws and regulations of each country. A written informed consent was provided by participants for both the studies. Appropriate measures were taken to ensure the confidentiality of the data.